Iain Wilkie
Stock Analyst at Morgans
(0.12)
# 4,488
Out of 4,575 analysts
146
Total ratings
28.8%
Success rate
-12.9%
Average return
Main Sectors:
Stocks Rated by Iain Wilkie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: NUZ Neurizon Therapeutics Limited | Maintained: Buy | $0.20 | $0.06 | +233.33% | 10 | Jul 19, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Maintained: Buy | $0.12 | $0.05 | +166.67% | 10 | Jul 16, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $210.00 → $230.00 | $159.82 | +43.91% | 28 | Jul 14, 2026 | |
| ASX: EIQ Echo IQ Limited | Maintained: Buy | $1.30 → $1.85 | $1.32 | +40.68% | 2 | Jul 14, 2026 | |
| ASX: M7T Mach7 Technologies Limited | Maintained: Buy | $0.76 → $0.44 | $0.30 | +49.15% | 8 | Apr 27, 2026 | |
| ASX: SOM SomnoMed Limited | Maintained: Buy | $0.99 | $0.45 | +120.00% | 19 | Mar 2, 2026 | |
| ASX: IME ImExHS Limited | Maintained: Buy | $0.35 → $0.50 | $0.31 | +63.93% | 13 | Mar 2, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $14.00 → $13.00 | $10.06 | +29.22% | 6 | Feb 27, 2026 | |
| ASX: NAN Nanosonics Limited | Maintained: Buy | $5.00 → $4.00 | $2.98 | +34.23% | 7 | Feb 25, 2026 | |
| ASX: PIQ Proteomics International Laboratories Ltd | Downgraded: Sell | $0.43 | $0.16 | +177.42% | 7 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.58 → $0.24 | $0.00 | n/a | 8 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.22 → $0.29 | $0.03 | n/a | 4 | Sep 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.28 → $0.78 | $0.17 | n/a | 14 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.43 | $0.08 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.31 → $1.24 | $0.27 | n/a | 4 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.89 → $1.64 | $0.01 | n/a | 3 | Feb 16, 2022 |
Neurizon Therapeutics Limited
Jul 19, 2026
Maintained: Buy
Price Target: $0.20
Current: $0.06
Upside: +233.33%
Microba Life Sciences Limited
Jul 16, 2026
Maintained: Buy
Price Target: $0.12
Current: $0.05
Upside: +166.67%
Pro Medicus Limited
Jul 14, 2026
Maintained: Buy
Price Target: $210.00 → $230.00
Current: $159.82
Upside: +43.91%
Echo IQ Limited
Jul 14, 2026
Maintained: Buy
Price Target: $1.30 → $1.85
Current: $1.32
Upside: +40.68%
Mach7 Technologies Limited
Apr 27, 2026
Maintained: Buy
Price Target: $0.76 → $0.44
Current: $0.30
Upside: +49.15%
SomnoMed Limited
Mar 2, 2026
Maintained: Buy
Price Target: $0.99
Current: $0.45
Upside: +120.00%
ImExHS Limited
Mar 2, 2026
Maintained: Buy
Price Target: $0.35 → $0.50
Current: $0.31
Upside: +63.93%
Clinuvel Pharmaceuticals Limited
Feb 27, 2026
Maintained: Buy
Price Target: $14.00 → $13.00
Current: $10.06
Upside: +29.22%
Nanosonics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $5.00 → $4.00
Current: $2.98
Upside: +34.23%
Proteomics International Laboratories Ltd
Feb 2, 2026
Downgraded: Sell
Price Target: $0.43
Current: $0.16
Upside: +177.42%
Sep 2, 2024
Maintained: Buy
Price Target: $0.58 → $0.24
Current: $0.00
Upside: n/a
Sep 1, 2022
Maintained: Buy
Price Target: $0.22 → $0.29
Current: $0.03
Upside: n/a
Mar 9, 2022
Downgraded: Sell
Price Target: $1.28 → $0.78
Current: $0.17
Upside: n/a
Feb 28, 2022
Maintained: Buy
Price Target: $1.43
Current: $0.08
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1.31 → $1.24
Current: $0.27
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $1.89 → $1.64
Current: $0.01
Upside: n/a